aspartic acid has been researched along with Bleeding in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Guo, Y; Huang, Y; Jiang, J; Li, Y; Ren, J; Zhao, Q; Zhou, J | 1 |
| Dangelmaier, C; Kostyak, JC; Kunapuli, SP; Mauri, B; Patel, A | 1 |
| Cole, G; Gabrail, NY; James, D; Khorana, AA; Ramanathan, RK; Shah, S; Thomas, GW; Wong, S; Zhou, C | 1 |
| Abshire, TC; Branchford, BR; Brown, DL; Christopherson, PA; Di Paola, JA; Dunn, AL; Flood, VH; Friedman, KD; Gill, JC; Haberichter, SL; Hoffmann, RG; Hoots, WK; Leissinger, C; Lusher, JM; Montgomery, RR; Ragni, MV; Shapiro, AD | 1 |
| Barker, WC; Mazumder, R; Sagripanti, JL; Vasudevan, S; Wu, CH | 1 |
| Jílek, I; Mourek, J; Trávnícková, E; Trojan, S | 1 |
1 trial(s) available for aspartic acid and Bleeding
| Article | Year |
|---|---|
A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Benzimidazoles; Blood Coagulation; Carcinoma, Pancreatic Ductal; Deoxycytidine; Drug Monitoring; Factor VIIa; Female; Gemcitabine; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Pancreatic Neoplasms; Progression-Free Survival; Time Factors | 2019 |
5 other study(ies) available for aspartic acid and Bleeding
| Article | Year |
|---|---|
A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.
Topics: Animals; Arginine; Aspartic Acid; Chitosan; Fibrinogen; Fibrinolytic Agents; Glycine; Hemorrhage; Hemostatics; Mice; Oligopeptides; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 2022 |
D121 Located within the DRY Motif of P2Y12 Is Essential for P2Y12-Mediated Platelet Function.
Topics: Adenosine Diphosphate; Animals; Aspartic Acid; Blood Platelets; Hemorrhage; Humans; Mice; Platelet Aggregation; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12 | 2022 |
No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.
Topics: Amino Acid Substitution; Aspartic Acid; Case-Control Studies; Hemorrhage; Histidine; Humans; Incidence; Mutation, Missense; Research Design; Severity of Illness Index; von Willebrand Disease, Type 1; von Willebrand Factor | 2013 |
Sequence signatures in envelope protein may determine whether flaviviruses produce hemorrhagic or encephalitic syndromes.
Topics: Amino Acid Sequence; Asparagine; Aspartic Acid; Encephalitis, Viral; Flavivirus; Hemorrhage; Humans; Models, Molecular; Molecular Sequence Data; Protein Structure, Tertiary; Sequence Homology, Amino Acid; Viral Envelope Proteins; Virulence Factors | 2009 |
Some metabolic changes in the nervous tissue of young rats after repeated blood loss.
Topics: Adaptation, Physiological; Aminobutyrates; Animals; Aspartic Acid; Basal Ganglia; Blood Volume; Brain; Cerebellum; Cerebral Cortex; Chromatography, Paper; Diencephalon; Glutamates; Glycogen; Glycolysis; Hemorrhage; Lactates; Medulla Oblongata; Oxygen Consumption; Pons; Rats | 1970 |